CARNABIOSCIENCES-C1763102
Phase I
OPEN TO ACCRUAL
A Phase 1b Study of Oral AS-1763 in Patients with Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non Hodgkin Lymphoma
IIT-GEORGE-I-PREDICT
Phase I/II
OPEN TO ACCRUAL
An Open-Label, Navigational Investigation of Profile-Related Evidence Determining Individualized Cancer Therapy for Patients with Aggressive Malignancies and Poor Prognoses
- Anus
- Bones and Joints
- Brain and Nervous System
- Breast
- Cervix
- Colon
- Corpus Uteri
- Esophagus
- Eye and Orbit
- Hodgkin's Lymphoma
- Ill-Defined Sites
- Kaposi's Sarcoma
- Kidney
- Larynx
- Lip, Oral Cavity and Pharynx
- Liver
- Lung
- Melanoma, Skin
- Other Digestive Organ
- Other Endocrine System
- Other Female Genital
- Other Male Genital
- Other Respiratory and Intrathoracic Organs
- Other Skin
- Other Urinary
- Ovary
- Pancreas
- Prostate
- Rectum
- Small Intestine
- Soft Tissue
- Stomach
- Thyroid
- Unknown Sites
- Urinary Bladder
IIT-GORE-REDIRICT
Phase II
OPEN TO ACCRUAL
High Dose Re-Irradiation Utilizing Advanced Deformable Image Registration (DIR) and Individualized Organ At Risk (OAR) Dose Calculations with Organ Specific Toxicity Analysis (Re-DIRICT)
- Anus
- Brain and Nervous System
- Breast
- Cervix
- Colon
- Esophagus
- Kidney
- Larynx
- Lip, Oral Cavity and Pharynx
- Liver
- Lung
- Other Digestive Organ
- Other Endocrine System
- Other Female Genital
- Other Male Genital
- Other Respiratory and Intrathoracic Organs
- Other Urinary
- Ovary
- Pancreas
- Prostate
- Rectum
- Small Intestine
- Soft Tissue
- Stomach
- Thyroid
- Unknown Sites
- Urinary Bladder